Skip to content
Review

Clinical Outcomes and Safety of CDK4/6 Inhibitors Combined with Endocrine Therapy in Male Patients with HR+/HER2 − Advanced or Metastatic Breast Cancer: A Systematic Review and Exploratory Meta-analysis

Oct 2026 · SN Comprehensive Clinical Medicine · Vol 8 · 0 citations · 22 references
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.